Isomerase

Isomerase helps partners innovate and harness the microbial power of a wide range of bacteria and fungi to discover and produce native or novel natural products, peptides, and enzymes sustainably, cost effectively and at scale. Isomerase leverages its decades of experience working with bacteria and fungi, combined with its knowledge, capabilities and innovations in biology, chemistry, and bioprocessing, to enable partners to progress their products and processes toward commercialisation

Analogue generation,analytical chemistry,biocatalysis,bioinformatics,biomanufacturing,bioprocess development,consulting services,enzyme engineering,fermentation,microbial strains,natural product chemistry,natural products,peptides,proteins,scale-up,strain bioengineering,sustainability,synthetic biology,tech transfer,and usp and dsp development

Isomerase operates in the Biotechnology research industry.

Isomerase's revenue is 11m - 100m

Isomerase has 11 - 50 employees.